The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $604,852 Project Grant (CFDA 93.853) to Childrens Hospital Medical Center in Cincinnati, Ohio to conduct research on medulloblastoma, the most common malignant childhood brain tumor. The 5-year research project aims to investigate the role of glial progenitor cells in the initiation and recurrence of medulloblastoma, with the goal of identifying new therapeutic targets to improve patient survival while minimizing adverse side effects. The research will utilize single-cell analysis of tumor tissues to characterize the tumor heterogeneity, evolution, and microenvironment during recurrence, as well as define the signaling mechanisms and regulatory circuits driven by glial fate determinants that may promote medulloblastoma recurrence. This work aligns with the Extramural Research Programs in the Neurosciences and Neurological Disorders, which supports scientific research to understand brain and nervous system function, neurological disorders, and potential therapeutic interventions.
Generated 3/25/25, 4:19 AM